指南与共识细胞病理与分子病理

欧洲细胞病理实验室免疫细胞化学实践:EFCS在线调查结果与最佳实践建议

Immunocytochemistry practices in European cytopathology laboratories-Review of European Federation of Cytology Societies (EFCS) online survey results with best practice recommendations.
指南 / 共识 · Cancer Cytopathol · 2020-06-29

该研究通过欧洲细胞病理学会联盟(EFCS)向欧洲实验室发放19题在线调查,评估细胞学样本免疫细胞化学(ICC)的前分析和分析环节实践。截至2019年1月30日共245家实验室回复,显示ICC广泛开展于自动化平台,但多数缺乏质量保证措施,存在显著操作变异性。

要点

  • 欧洲245家实验室中60%混用多种细胞学制备行ICC,40%仅用单一类型。
  • 96%(217/226)实验室在自动化平台行ICC,45%(238/527)沿用FFPE方案。
  • 阳性对照、阴性对照和外部质控使用率分别为78%、50%和50%。

核心结论

  • ICC在欧洲实验室广泛开展,但前分析和分析步骤变异性大,且多数缺乏质量保证措施。

研究设计与样本

  • 通过EFCS国家代表向欧洲细胞病理实验室发放19题在线调查,截至2019年1月30日共245家实验室回复。

主要发现

  • 细胞块、细胞离心、液基细胞学(LBC)和涂片单独或联合用于ICC的实验室分别占38%、22%、21%和19%。
  • 60%(147/245)实验室使用多种制备组合行ICC,40%(98/245)仅用单一类型制备。
  • 96%(217/226)实验室在自动化平台行ICC;45%(238/527)沿用FFPE方案,26%(138/527)优化,29%(151/527)优化并验证。
  • 阳性对照、阴性对照和外部质控使用率分别为78%(174/223)、50%(112/223)和50%(111/120)。
  • 34%(65/191)实验室年ICC检测量>1000例(平均1477例,中位500例)。

临床怎么用

  • 建议实验室针对细胞学制备优化并验证ICC方案,而非直接沿用FFPE流程。
  • 应常规设置阳性和阴性对照,并参加外部质量评估以提升ICC质量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Variability in preanalytical and analytical steps for immunocytochemistry (ICC) on cytology samples is poorly defined. The objective of this study was to evaluate current practices for ICC on cytology samples in European laboratories. METHODS: A link to an online survey with 19 questions about ICC practices was distributed to cytology laboratories through national representatives in the European Federation of Cytology Societies. RESULTS: In total, 245 laboratories responded to the survey by January 30, 2019. Cell blocks, cytospins, liquid-based cytology (LBC) preparations, and smears alone or in combination with other preparations were used for ICC in 38%, 22%, 21%, and 19% of laboratories, respectively. In general, various combinations of preparations were used for ICC in greater than one-half of laboratories (147 of 245; 60%), whereas only 1 specific type of cytology preparation was used in the remaining 98 of 245 laboratories (40%) laboratories. The majority of laboratories (217 of 226; 96%) performed ICC on automated platforms using protocols that were the same as those used for formalin-fixed, paraffin-embedded samples (238 of 527 laboratories; 45%), either optimized (138 of 527 laboratories; 26%) or optimized and validated (151 of 527 laboratories; 29%) for cytology preparations. Positive control slides, negative control slides, and external quality control were used in 174 of 223 (78%), 112 of 223 (50%), and 111 of 120 (50%) laboratories, respectively. Greater than 1000 ICC tests were performed yearly in 34% of laboratories (65 of 191; average, 1477 tests; median, 500 tests). CONCLUSIONS: ICC is extensively performed in European laboratories using variously prepared cytology preparations on automated platforms, mostly without quality-assurance measures.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Srebotnik Kirbiš I, Rodrigues Roque R, Bongiovanni M, et al. Immunocytochemistry practices in European cytopathology laboratories-Review of European Federation of Cytology Societies (EFCS) online survey results with best practice recommendations. Cancer Cytopathol. 2020. PMID: 32598103. doi:10.1002/cncy.22311

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。